SCHEMBL23033477

SCHEMBL23033477

CN(N)/N=C(\N)C(c1ccccc1)N1CCN(C(=O)c2cc(-c3nc4cc(O)ccc4o3)ccn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.38
▸ NPSR1 Q6W5P4 5/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ TP53 P04637 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ RECQL P46063 1/20 0.38
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ APP P05067 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ ESR1 P03372 4/20 0.35
▸ ESR2 Q92731 4/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MGLL Q99685 2/20 0.34
▸ NR2E1 Q9Y466 1/20 0.34
▸ HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23033324 0.93 PIK3CB (0.37) LMNANPSR1KMT2ATP53MAPT
SCHEMBL23033321 0.88 ALDH1A1 (0.39) LMNANPSR1TP53MAPTALDH1A1
SCHEMBL23033956 0.85 KDM4E (0.37) LMNANPSR1TP53MAPTALDH1A1
SCHEMBL23033326 0.84 PTGS2 (0.36) NPSR1TP53MAPTALDH1A1SMN1; SMN2
SCHEMBL23033647 0.82 MAPT (0.41) NPSR1TP53MAPTALDH1A1SMN1; SMN2
SCHEMBL23033680 0.81 NR2E1 (0.33) LMNANPSR1KMT2ATP53MAPT
SCHEMBL23034044 0.78 ALDH1A1 (0.46) LMNANPSR1TP53MAPTALDH1A1
SCHEMBL23033970 0.78 PTGS2 (0.41) LMNANPSR1TP53MAPTALDH1A1
SCHEMBL23033960 0.78 CASP3 (0.46) NPSR1KMT2AMAPTALDH1A1MEN1
SCHEMBL23012956 0.77 LMNA (0.42) LMNANPSR1KMT2ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032209-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF 四川海思科制药有限公司 2021-02-25 — — WO disclosed
Send feedback